Short (1992) |
Consecutive series |
22, greater than 40 > 3 mo post injury |
EEG, EMG, EOS Trunk strain gauges O2 sats |
Hypopnea is O2 > 4% drop from preceding 10 minute average |
55% AHI > 5 27% AHI > 15 2 central apnea |
No relationship to age, time since injury, obesity, spirometry |
McEvoy (1995) |
Regional cohort |
44, C8 and above, ASIA A, B, C >6 mo post injury |
Home sleep studyEEG, EOG, submental EMG, body movement, nasal air flow, respiratory movement, SPO2
|
Hypopnea = 10 second of >50% airflow drop from baseline |
30% AI ≥ 5 27.5% AHI ≥ 15 |
AHI related to systolic bp, diastolic bp, neck circumference, supine position |
Klefbeck (1998) |
Consecutive series |
33 C4-T1 ASIA A-D 3 C4, 12 C5, 9 C6, 5 C7, 1 C8, 2T1 |
Hospital sleep labO2, body movement |
Hypopnea is O2 > 4% drop |
15% met criteria |
Related to ASIA level in ASIA A group only |
Stockhammer (2002) |
Random selection |
50, C3-C8 23 C3-5, 27 C6-8 40 ASIA A-B |
Hospital sleep lab O2, nasal thermistor, chest wall motion |
Hypopnea 50–90% drop airflow for 10 secApnea > 90% drop for 10 sec |
48% AI ≥ 5 62% AHI ≥ 15 |
AHI related to age, male sex, BMI. |
Berlowitz (2005) |
Inception cohort |
30, 13 finished 52 week evaluation C4 9, C5 10, C6 2, C7 1, C8 1 ASIA 1-B 20% |
Hospital sleep labEEG, submental and diaphragm EMG, EOG, ECG, nasal thermistor, plethysmography, SP 02
|
Hypopnea defined as 50% reduced airflow or <50% airflow and >3% O2 drop Apnea defined as no airflow |
60% AHI ≥ 5 by 2 weeks, then stable |
|
LeDuc (2007) |
Prospective cohort |
41 outpatients |
Home unsupervised polygrams |
Symptoms plus AHI Hypopnea 50% reduction in airflow or >3% drop O2
|
56% AHI ≥ 5 |
No relationship of symptoms to AHIOSA related to daytime sleepiness, BMI greater than 30 kg/m2, neck circumference and greater than 3 awakenings at night |
Berlowitz (2012) |
Cross sectional |
78, tetraplegia |
Hospital sleep labEEG, submental and diaphragm EMG, EOG, ECG, nasal thermistor, plethysmography, SP 02
|
AHI > 10 |
91% complete with SDB 56% incomplete |
No relationship between AHI and ASIA level |
Sankari (2014 J Appl Physiol) |
Case Control |
16 SCI (6 cervical) and 16 control |
Non-invasive hyperventilation to induce apnea, CO2 trial to abolish central apneaPolysomnogram |
AHI > 5 |
Central SDB 63% cervical, 13% thoracic CO2 reserve narrower in cervical, best in controls. |
|
Sankari (2014 JCSM) |
Consecutive Series |
26, 15 cervical |
Hospital sleep study Polysomnogram: EEG, submental EMG, nasal air flow, pharyngeal pressure, ETCO2, upper airway resistance Epworth, Pittsburgh, Berlin, Fatigue severity |
AHI > 5 Central AI > 5 |
PSQ 10.3, ESS 10.4 Fatigue 96%, daytime sleepiness 59%, Berlin high risk 46%. AHI >5 77%, 89% cervical, 50% thoracic. Central AI 33% cervical, 13% thoracic. |
|
TREATMENT |
|
|
|
|
|
|
Burns (2005) |
Postal survey |
40 of 72 being treated for SDB |
|
|
CPAP tried by 80%, used by 63%. Reasons: 67% unable to fall asleep, 42% discomfort, 33% claustrophobia |
No difference in symptoms between users and non-users |
Berkowitz (2009) |
Prospective cohort |
74% of 19 with SCI and AHI >10 |
Auto-titration CPAP with PT support for 3–4 nights |
|
|
Patients who tolerated CPAP were older, had higher BMI, were sleepier and had more severe OSA |
Leguen (2012) |
Retrospective Case Control |
25 SCI, 219 controls with OSA |
|
|
|
No relationship between effective use and BMI or AHI |